Skip to main content
Year archive

ADALTA LIMITED — 2024 filings

All 73 regulatory filings released by ADALTA LIMITED (1AD) in 2024, sourced directly from the official regulator.

73 Filings
2024 Period
2024 filings (73)
Filing Released Lang
Notification regarding unquoted securities - 1AD 7 pages 23.0KB
Share Issue/Capital Change
2024-12-04 English
Change of Director's Interest Notice (TO) 4 pages 333.0KB
Director's Dealing
2024-12-04 English
Presentation at ASCEPT, APFP & APSA Joint Congress 27 pages 4.0MB
Investor Presentation
2024-12-01 English
Initial Director's Interest Notice X 2 (MB & IR) 4 pages 281.6KB
Director's Dealing
2024-11-20 English
Final Director's Interest Notice (RP) 2 pages 288.5KB
Director's Dealing
2024-11-20 English
Investor Presentation 49 pages 4.0MB
Investor Presentation
2024-11-20 English
Chair address and CEO presentation to AGM 31 pages 2.9MB
AGM Information
2024-11-19 English
Results of Meeting 3 pages 216.1KB
Declaration of Voting Results & Voting Rights Announcements
2024-11-19 English
Board changes 3 pages 205.5KB
Board/Management Information
2024-11-17 English
Change in substantial holding 3 pages 159.3KB
Regulatory Filings
2024-11-04 English
Application for quotation of securities - 1AD 6 pages 18.5KB
Share Issue/Capital Change
2024-11-03 English
Cleansing Notice under Section 708A 1 page 186.0KB
Share Issue/Capital Change
2024-11-03 English
ASX Gems Investor Presentation 2 pages 192.5KB
Investor Presentation
2024-10-29 English
Quarterly Appendix 4C and Activities Report 11 pages 407.3KB
Interim / Quarterly Report
2024-10-23 English
Chief Medical Officer Appointments 3 pages 206.3KB
Board/Management Information
2024-10-22 English
Letter to Shareholders, Notice of AGM & Proxy Form 35 pages 665.2KB
AGM Information
2024-10-17 English
AD-214 clinical advisory board 3 pages 209.5KB
Board/Management Information
2024-10-09 English
FY24 RDTI Refund Received $1.77m 3 pages 212.1KB
Capital/Financing Update
2024-10-03 English
Change of Director's Interest Notice 4 pages 328.4KB
Director's Dealing
2024-09-09 English
Application for quotation of securities - 1AD 6 pages 18.5KB
Share Issue/Capital Change
2024-09-04 English
Cleansing Notice under Section 708A 1 page 211.2KB
Share Issue/Capital Change
2024-09-04 English
Proposed issue of securities - 1AD 6 pages 20.4KB
Capital/Financing Update
2024-09-01 English
Transaction, investment facility update 3 pages 200.2KB
Capital/Financing Update
2024-09-01 English
Change in substantial holding 5 pages 212.8KB
Regulatory Filings
2024-08-29 English
Preliminary Final Report 2 pages 259.4KB
Earnings Release
2024-08-27 English
Annual Report to shareholders 70 pages 3.0MB
Annual Report
2024-08-27 English
Appendix 4G and Corporate Governance Statement 30 pages 795.3KB
Regulatory Filings
2024-08-27 English
Investor events and presentation 47 pages 3.7MB
Investor Presentation
2024-08-20 English
Quarterly Appendix 4C and Activities Report 11 pages 451.1KB
Interim / Quarterly Report
2024-07-28 English
Results of Meeting 3 pages 172.3KB
Declaration of Voting Results & Voting Rights Announcements
2024-07-22 English
Notification regarding unquoted securities - 1AD 6 pages 18.5KB
Share Issue/Capital Change
2024-07-03 English
Investor Webinar Invitations 2 pages 184.5KB
Investor Presentation
2024-06-17 English
Change of registered address 2 pages 180.9KB
Regulatory Filings
2024-06-17 English
Letter to Shareholders, Notice of EGM & Proxy Form 28 pages 583.9KB
Proxy Solicitation & Information Statement
2024-06-16 English
Change in substantial holding 3 pages 158.6KB
Regulatory Filings
2024-06-03 English
Change in substantial holding 3 pages 257.8KB
Major Shareholding Notification
2024-06-02 English
Application for quotation of securities - 1AD 20 pages 501.6KB
Capital/Financing Update
2024-06-02 English
$1.9 million raised from exercise of 1ADOA options 3 pages 217.1KB
Capital/Financing Update
2024-06-02 English
Change in substantial holding 4 pages 187.6KB
Regulatory Filings
2024-05-29 English
Application for quotation of securities - 1AD 20 pages 489.5KB
Regulatory Filings
2024-05-28 English
Application for quotation of securities - 1AD 6 pages 18.1KB
Share Issue/Capital Change
2024-05-20 English
Investor presentation 47 pages 9.6MB
Investor Presentation
2024-05-19 English
Application for quotation of securities - 1AD 6 pages 18.1KB
Share Issue/Capital Change
2024-05-13 English
Cellular immunotherapy manufacturer secured - Cell Therapies 4 pages 216.9KB
Capital/Financing Update
2024-05-12 English
Application for quotation of securities - 1AD 6 pages 18.6KB
Share Issue/Capital Change
2024-05-08 English
Cleansing Notice under Section 708A 1 page 275.0KB
Share Issue/Capital Change
2024-05-08 English
Application for quotation of securities - 1AD 6 pages 18.1KB
Share Issue/Capital Change
2024-05-06 English
Investor webinar presentation 10 pages 2.8MB
Investor Presentation
2024-04-30 English
Application for quotation of securities - 1AD 6 pages 18.1KB
Share Issue/Capital Change
2024-04-30 English
Investor webinar 2 pages 199.2KB
Capital/Financing Update
2024-04-29 English
Application for quotation of securities - 1AD 7 pages 21.2KB
Share Issue/Capital Change
2024-04-29 English
Application for quotation of securities - 1AD 6 pages 19.0KB
Regulatory Filings
2024-04-28 English
Proposed issue of securities - 1AD 6 pages 20.9KB
Capital/Financing Update
2024-04-28 English
Proposed issue of securities - 1AD 5 pages 18.7KB
Capital/Financing Update
2024-04-28 English
Quarterly Appendix 4C and Activities Report 12 pages 440.0KB
Interim / Quarterly Report
2024-04-28 English
Institutional investment to pursue strategic initiatives 4 pages 234.7KB
Capital/Financing Update
2024-04-28 English
Extension of Victorian Government RDTI Loan Facility 3 pages 176.3KB
Capital/Financing Update
2024-04-28 English
Cleansing Notice under Section 708A 1 page 275.1KB
Share Issue/Capital Change
2024-04-28 English
Cleansing Notice under Section 708A 1 page 276.8KB
Share Issue/Capital Change
2024-04-28 English
Notification of Expiry of Listed Options 5 pages 722.3KB
Share Issue/Capital Change
2024-04-23 English
SYNBV MoU Webinar presentation 18 pages 2.8MB
Investor Presentation
2024-04-09 English
SYNThesis BioVentures MoU for cellular immunotherapies 6 pages 239.7KB
Capital/Financing Update
2024-04-07 English
Webinar to discuss SYNthesis BioVentures partnership 2 pages 199.2KB
Regulatory Filings
2024-04-07 English
AdAlta presenting at ASX Gems conference 2 pages 181.5KB
Investor Presentation
2024-03-19 English
Application for quotation of securities - 1AD 6 pages 18.1KB
Share Issue/Capital Change
2024-03-14 English
Corporate Presentation 30 pages 7.1MB
Investor Presentation
2024-03-07 English
Share Cafe webinar on Phase I results 2 pages 160.2KB
Investor Presentation
2024-03-06 English
Positive AD-214 Phase I extension study results 6 pages 359.3KB
Capital/Financing Update
2024-03-05 English
Half Yearly Report and Accounts 24 pages 2.4MB
Interim / Quarterly Report
2024-02-26 English
Australia Biologics Festival Presentation 27 pages 7.8MB
Investor Presentation
2024-02-19 English
Quarterly Appendix 4C and Activities Report 11 pages 594.3KB
Interim / Quarterly Report
2024-01-30 English
January 2024 partnering presentations and progress 20 pages 3.8MB
Capital/Financing Update
2024-01-21 English
Notification regarding unquoted securities - 1AD 7 pages 30.3KB
Share Issue/Capital Change
2024-01-09 English